Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2012
08/28/2012US8252304 Semi-solid delivery vehicle and pharmaceutical compositions for delivery of granisetron
08/28/2012US8252303 A biodegradable, biocompatible polymer, a water-immiscible solvent to plasticize the polymer and form a gel, a thixotropic agent and a beneficial agent; drug delivery; improved shear thinning and reduced injection
08/28/2012US8252276 Cyclodextrin-based polymers for therapeutics delivery
08/28/2012US8252275 Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates
08/28/2012US8252268 Formoterol and mometasone aerosol formulations
08/28/2012US8252046 Drug-delivery endovascular stent and method for treating restenosis
08/28/2012CA2657476C Protein-binding methotrexate derivatives and medicaments containing the same
08/28/2012CA2645724C Use of polyols to obtain stable polymorphous forms of rifaximin
08/28/2012CA2537993C Dual phase drug release system
08/28/2012CA2529290C Pharmaceutical compositions comprising peranhydrocyclodextrin
08/28/2012CA2506319C Stents comprising biodegradable polymers associated with therapeutic agents
08/28/2012CA2492470C Stable pharmaceutical composition comprising erythropoietin
08/28/2012CA2476540C Basic magnesium carbonate, production method and use of the same
08/28/2012CA2447391C Substantially homogeneous bio-affecting material having a pre-determined ratio of transferrin to doxorubicin, its method of manufacture and its method of use
08/28/2012CA2409930C Use of zoledronate for the manufacture of a medicament for the treatment of bone metabolism diseases
08/28/2012CA2389345C Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
08/28/2012CA2387805C Nucleic acids encoding endotheliases, endotheliases and uses thereof
08/25/2012CA2731871A1 Use of enhancers, possibly associated to riboflavin, as well as corresponding ophthalmic compositions for corneal cross-linking in the treatment of the keratoconus or of other corneal ectasic disorders
08/23/2012WO2012112767A2 Collagen-targeted nanoparticles
08/23/2012WO2012112708A1 Cytotoxic benzodiazepine derivatives and methods of preparation
08/23/2012WO2012112690A2 Targeting of therapeutic drugs and diagnostic agents employing collagen binding domains
08/23/2012WO2012112689A1 Nanoparticle, liposomes, polymers, agents and proteins modified with reversible linkers
08/23/2012WO2012112687A1 Methods of preparation of conjugates
08/23/2012WO2012112426A1 Arginine vasopressin retargeted clostridial endopeptidases for use in treating benign prostatic hyperplasia
08/23/2012WO2012112355A1 Methods for controlling pain in equines using a transdermal solution of fentanyl
08/23/2012WO2012112188A1 Hsa-related compositions and methods of use
08/23/2012WO2012111996A2 Transdermal delivery system containing galantamine or salts thereof
08/23/2012WO2012111965A2 Orally administered sustained-release triple-layer pill containing tamsulosin or pharmaceutically acceptable salt thereof
08/23/2012WO2012111762A1 Highly concentrated anti-cd40 antibody pharmaceutical preparation
08/23/2012WO2012111627A1 Nanoparticle containing prostaglandin i2 derivative
08/23/2012WO2012110971A2 Method and composition to retard sorption of preservatives to plastics
08/23/2012WO2012110636A2 Carrier peptides for cell delivery
08/23/2012WO2012110596A1 Fusion protein for the treatment of immunologic or allergic reactions
08/23/2012WO2012110430A1 Novel composition for topical use on a nail
08/23/2012WO2012109975A1 Pegylated analogue protein of canine urate oxidase, preparation method and use thereof
08/23/2012WO2012109755A1 Fatty ester-based particles and methods of preparation and use thereof
08/23/2012WO2012109732A1 Compositions comprising self-assembling peptide and amino acid vehicles and active agents pp1 or pp2 and uses thereof
08/23/2012WO2012098342A8 (r)-1,2-propanediol for use as a solvent in therapeutic cooling agent compositions
08/23/2012WO2012091518A3 Phospholipid nanoparticles for mr-induced high-intensity focused ultrasonic treatment and diagnosis, and method for producing same
08/23/2012WO2012091278A3 Nanoemulsion-type ophthalmic composition
08/23/2012WO2012091165A9 Method for utilizing monoterpene glycosyltransferase
08/23/2012WO2012087062A3 Sustained-release polymeric microparticles containing poorly water-soluble drug and method for preparing the same
08/23/2012WO2012077950A3 Hyaluronic acid-protein conjugate and method for preparing same
08/23/2012WO2012074440A3 Pharmacological composition intended for intra-nasal administration with the aim of supplying a pharmacologically active component to the brain, and method for producing said composition
08/23/2012WO2012061443A3 Compositions of a peptide targeting system for treating cancer
08/23/2012WO2012039954A3 Reliable stabilization of n-linked polypeptide native states with enhanced aromatic sequons located in polypeptide tight turns
08/23/2012WO2012021882A3 Formulation, apparatus and method for stabilizing radiopharmaceuticals
08/23/2012WO2012012541A3 SUSTAINED RELEASE siRNA FOR OCULAR DRUG DELIVERY
08/23/2012WO2011163483A3 Polymers for biomaterials and therapeutics
08/23/2012US20120214874 Pharmaceutical formulations and methods of use
08/23/2012US20120214775 Pharmaceutical Salts of 3-O-(3',3'-Dimethylsuccinyl) Betulinic Acid
08/23/2012US20120214773 Formulation for lipophilic agents
08/23/2012US20120214206 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS
08/23/2012US20120213872 Compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof
08/23/2012US20120213854 Methods of treating a subject and related particles, polymers and compositions
08/23/2012US20120213850 Controlled Release and Taste Masking Oral Pharmaceutical Composition
08/23/2012US20120213843 Composition for promoting wound healing
08/23/2012US20120213842 Methods of making and using compositions comprising flavonoids
08/23/2012US20120213839 Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
08/23/2012US20120213831 Microspheres for active embolization
08/23/2012US20120213823 Compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof
08/23/2012US20120213817 Chimeric rsv-f polypeptide and lentivirus or alpha-retrovirus gag-based vlps
08/23/2012US20120213816 Mycoplasma hyopneumoniae bacterin vaccine
08/23/2012US20120213804 Calicheamicin derivative-carrier conjugates
08/23/2012US20120213732 Targeted delivery of antiviral compounds through hemoglobin bioconjugates
08/23/2012US20120213730 Alteration of cell membrane for new functions
08/23/2012US20120213701 Methods for tumor diagnosis and therapy
08/23/2012US20120213697 Versatile nanoparticulate biomaterial for controlled delivery and/or containment of therapeutic and diagnostic material
08/23/2012CA2827488A1 Methods for controlling pain in equines using a transdermal solution of fentanyl
08/23/2012CA2827470A1 Transdermal delivery system containing galantamine or salts thereof
08/23/2012CA2826683A1 Hsa-related compositions and methods of use
08/23/2012CA2825919A1 Methods of preparation of conjugates
08/22/2012EP2489653A1 Method for producing reduced coenzyme q10, method for stabilizing same, and composition comprising same
08/22/2012EP2489652A1 Method for producing reduced coenzyme q10, method for stabilizing same, and composition comprising same
08/22/2012EP2489372A2 Binding ligand linked drug delivery conjugates of tubulysins
08/22/2012EP2489371A1 Carrier peptides for drug delivery
08/22/2012EP2489364A1 Monomethylvaline compounds onjugated to antibodies
08/22/2012EP2489351A1 Inclusion complex of deoxypodophyllotoxin of cyclodextrin, preparation method, use for treament of cancer thereof
08/22/2012EP2489348A1 Pharmaceutical composition containing medicament-containing fine particles and method for producing same
08/22/2012EP2488637A1 Inhibitors of phosphatase and tensin homolog (pten) compositions, uses and methods
08/22/2012EP2488572A1 Method for preparing a recyclable polyamide powder
08/22/2012EP2488208A1 Compounds having peptides conjugated to bone targeting moieties and methods of making and using thereof
08/22/2012EP2488207A2 Polymeric systems for the delivery of anticancer agents
08/22/2012EP2488206A1 Porphyrin nanovesicles
08/22/2012EP2488175A2 Pharmaceutical compositions
08/22/2012EP2488172A2 Dendrimer compositions and methods of synthesis
08/22/2012EP2488164A2 Release of agents from cells
08/22/2012EP2488160A1 Liposomal amphotericin formulation comprising cholesterol for treating fungal infections
08/22/2012EP2488034A1 Antiseptic ointment comprising bentonite intercalated with silver, copper or zinc for external application
08/22/2012EP2488029A1 Methods and compositions for deterring abuse
08/22/2012EP2488018A1 Methods and compositions for novel liquid crystal delivery systems
08/22/2012EP2175834B8 Glp-1-fc fusion protein formulation
08/22/2012EP2011488B1 Transdermal patch containing rasagiline for treatment or prophylaxis of nervous system disease and its preparation process
08/22/2012EP1732524B1 Methods and compositions for treatment of ion imbalances
08/22/2012EP1526838B1 Intravenous pharmaceutical form of administration
08/22/2012EP1487426B1 Methods of inducing terminal differentiation
08/22/2012EP1399032B2 Improved hard sugar coating method
08/22/2012EP1051978B1 Crystallographically stable amorphous cephalosporin compositions and process for producing the same
08/22/2012CN1449825B Method for inactivating Bordetella bronchiseptica culture, bacteria composition prepared by same and vaccine having same and use thereof
08/22/2012CN1441676B Method of treatment using ligand-immunogen conjugates
1 ... 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 ... 1712